Literature DB >> 12213571

Inflammatory signal transduction in Crohn's disease and novel therapeutic approaches.

Catherine van Montfrans1, Maikel Peppelenbosch, Anje A te Velde, Sander van Deventer.   

Abstract

Although signal transduction phenomena are well understood in vitro, their relevance for physiology and pathophysiology remains obscure. Recent years, however, have seen a plethora of attempts to link cell biochemistry and disease. At the Luxembourg conference it was attempted to link basal science to disease. In my presentation I focused on our research on stress activated kinases and other signalling elements in this respect in a variety of pro-inflammatory conditions. Knowledge of these pathways has now led to new therapeutic approaches, especially in Crohn's disease, which will be the subject of this commentary.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213571     DOI: 10.1016/s0006-2952(02)01140-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

2.  Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.

Authors:  Vered Levin-Salomon; Konstantin Kogan; Natalie G Ahn; Oded Livnah; David Engelberg
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

3.  Evidence for aberrant regulation of MAP kinase signal transduction pathway in peripheral blood mononuclear cells in patients with active celiac disease.

Authors:  E Broide; E Scapa; O Bloch; M Shapiro; N A Kimchi; G Ben-Yehudah; M J Rapoport
Journal:  Dig Dis Sci       Date:  2008-09-12       Impact factor: 3.199

4.  Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment.

Authors:  Franco Scaldaferri; Carmen Correale; Antonio Gasbarrini; Silvio Danese
Journal:  Cell Adh Migr       Date:  2009-07-02       Impact factor: 3.405

5.  The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.

Authors:  Sabine Kersting; Volker Behrendt; Jonas Kersting; Kirstin Reinecke; Christoph Hilgert; Ingo Stricker; Thomas Herdegen; Monika S Janot; Waldemar Uhl; Ansgar M Chromik
Journal:  J Inflamm Res       Date:  2013-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.